[HTML][HTML] TNF in human tuberculosis: a double-edged sword

JM Yuk, JK Kim, IS Kim, EK Jo - Immune Network, 2024 - ncbi.nlm.nih.gov
TNF, a pleiotropic proinflammatory cytokine, is important for protective immunity and
immunopathology during Mycobacterium tuberculosis (Mtb) infection, which causes …

Diabetic pneumopathy-a novel diabetes-associated complication: pathophysiology, the underlying mechanism and combination medication

J Dwivedi, P Wal, B Dash, M Ovais… - … Metabolic & Immune …, 2024 - benthamdirect.com
> Background: The" diabetic lung" has been identified as a possible target organ in
diabetes, with abnormalities in ventilation control, bronchomotor tone, lung volume …

Drug exposure and treatment outcomes in patients with multidrug-resistant tuberculosis and diabetes mellitus: a multicenter prospective cohort study from China

Y Zhu, LD Forsman, C Chen, H Zhang… - Clinical Infectious …, 2024 - academic.oup.com
Background The management of multidrug-resistant tuberculosis (MDR-TB) remains
challenging. Treatment outcome is influenced by multiple factors; the specific roles of …

Helminth species dependent effects on Th1 and Th17 cytokines in active tuberculosis patients and healthy community controls

G Bewket, A Kiflie, F Tajebe, E Abate… - PLOS Neglected …, 2022 - journals.plos.org
Despite that the impact of different helminth species is not well explored, the current dogma
states that helminths affect the Th1/Th2 balance which in turn affects the risk of tuberculosis …

Impact of diabetes itself and glycemic control status on tuberculosis

F Meng, L Lan, G Wu, X Ren, X Yuan, M Yang… - Frontiers in …, 2023 - frontiersin.org
Objectives To explore the impact of diabetes itself and glycemic control status on
tuberculosis (TB). Methods A total of 3393 patients with TB and diabetes mellitus (DM) who …

Impact of diabetes mellitus on the immunity of tuberculosis patients: a retrospective, cross-sectional study

R Wei, P Li, Y Xue, Y Liu, W Gong… - Risk Management and …, 2022 - Taylor & Francis
Background Tuberculosis (TB) is an infectious disease that poses a significant health threat
and is one of the leading causes of death worldwide. Diabetes mellitus (DM) has high …

Pharmacokinetics-pharmacodynamics of first-line antitubercular drugs: a comparative study in tuberculosis patients with and without concomitant diabetes mellitus

S Mondal, V Roy, GG Meshram, A Khanna… - European Journal of …, 2024 - Springer
Purpose To observe the variability in the plasma concentrations and pharmacokinetic-
pharmacodynamic (PK-PD) profiles of first-line antitubercular drugs in pulmonary …

[图书][B] Integrated care for tuberculosis (TB) and diabetes mellitus (DM) comorbidity in asian countries: health system challenges and opportunities

World Health Organization - 2022 - apps.who.int
The high prevalence of TB and DM independently in Bangladesh, China, India, Indonesia,
Nepal and Philippines underscores the potential high prevalence of TB–DM comorbidity …

Comparison of CD4+/CD8+ Lymphocytic Subpopulations Pre-and Post-Antituberculosis Treatment in Patients with Diabetes and Tuberculosis

EJ Rendón Ramírez, AG Rosas-Taraco… - Pathogens, 2023 - mdpi.com
Is there a CD4+ and CD8+ immunity alteration in patients with pulmonary tuberculosis (TB)
and diabetes (DM) that does not recover after antituberculosis treatment? This prospective …

[HTML][HTML] A Comparative Investigation on Cytokine Expression in Pulmonary Tuberculosis and Comorbidity with Type 2 Diabetes Mellitus

K Singh, T Hussain, B Gupta, S Pati - The International Journal of …, 2024 - journals.lww.com
Background: Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis (TB),
with a high global prevalence and mortality rate. To control the gruesome pathogen, a deep …